Compare · ORPH vs SNOW
ORPH vs SNOW
Side-by-side comparison of Orphazyme A/S (ORPH) and Snowflake Inc. (SNOW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ORPH and SNOW operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- SNOW is the larger of the two at $101.65B, about 580.5x ORPH ($175.1M).
- SNOW has hit the wire 10 times in the past 4 weeks while ORPH has been quiet.
- SNOW has more recent analyst coverage (25 ratings vs 0 for ORPH).
- Company
- Orphazyme A/S
- Snowflake Inc.
- Price
- $0.86-5.49%
- $293.06-1.66%
- Market cap
- $175.1M
- $101.65B
- 1M return
- -
- +12.23%
- 1Y return
- -
- +40.58%
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2020
- News (4w)
- 0
- 10
- Recent ratings
- 0
- 25
Orphazyme A/S
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Snowflake Inc.
Snowflake Inc. provides cloud-based data platform in the United States and internationally. The company's platform offers Data Cloud, an ecosystem that enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of various sizes in a range of industries. The company was formerly known as Snowflake Computing, Inc. and changed its name to Snowflake Inc. in April 2019. Snowflake Inc. was incorporated in 2012 and is headquartered in San Mateo, California.
Latest ORPH
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form 20-F filed by Orphazyme A/S
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form NT 20-F/A filed by Orphazyme A/S (Amendment)
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form 6-K filed by Orphazyme A/S
- SEC Form NT 20-F filed by Orphazyme A/S
Latest SNOW
- Director Dageville Benoit sold $14,000,000 worth of shares (50,000 units at $280.00) as part of a pre-agreed trading plan and gifted 16,668 shares (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- Snowflake Advances the Trusted Agentic Enterprise Era with Unified Monitoring and Cost Management
- Director Slootman Frank exercised 300,000 shares at a strike of $8.88 and sold $82,323,691 worth of shares (300,000 units at $274.41) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- SEC Form 144 filed by Snowflake Inc.
- SEC Form 4 filed by Chief Executive Officer Ramaswamy Sridhar
- EVP, Product Management Kleinerman Christian sold $687,500 worth of shares (2,500 units at $275.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.63% to 395,379 units (SEC Form 4)
- Director Dageville Benoit sold $13,826,500 worth of shares (50,000 units at $276.53) as part of a pre-agreed trading plan and gifted 16,668 shares (SEC Form 4)
- Snowflake Inc. filed SEC Form 8-K: Leadership Update